Key result
Female sex linked to ~23% lower 2-year mortality or HF hospitalization after TEER.
Why the study?
Does female sex affect the 2-year composite outcome of all-cause mortality or heart failure hospitalization in patients undergoing transcatheter edge-to-edge repair for primary mitral regurgitation?
Observational (n=2,078)
Yes
Does female sex affect the 2-year composite outcome of all-cause mortality or heart failure hospitalization in patients undergoing transcatheter edge-to-edge repair for primary mitral regurgitation?
Answers are grounded in this paper and cite their sources.
Despite having lower optimal procedural results and higher residual mitral regurgitation after TEER for primary MR, female patients experienced higher adjusted 2-year survival and lower rates of the primary composite endpoint compared with male patients.
BACKGROUND: Sex-related differences have been previously explored in patients with mitral regurgitation (MR) undergoing surgery as well as those with secondary MR treated with transcatheter edge-to-edge repair (TEER). OBJECTIVES: This study sought to evaluate sex-related differences in baseline characteristics and clinical outcomes in patients undergoing TEER for primary MR. METHODS: Outcomes of Patients Treated with M-TEER for Primary MR (NCT05332782) is an international, retrospective registry including patients undergoing TEER for primary MR in 27 centers. The primary outcome was a composite of 2-year all-cause mortality or heart failure hospitalization. RESULTS: A total of 2,078 patients, including 961 (46.3%) females, were analyzed. Females were older and had fewer comorbidities but presented with a different anatomy and more advanced symptoms. Compared with males, females were more frequently excluded from surgery because of advanced age and frailty. Optimal procedural results were lower in females, with a higher incidence of residual MR ≥2+ (38.5% vs 32.1%; P = 0.0037), and a significantly higher mean transmitral gradient (4.0 vs 3.6 mm Hg; P < 0.001). Kaplan-Meier curves showed significantly lower rates of all-cause mortality and cardiovascular mortality in female patients. In contrast, the incidence of the primary composite endpoint, as well as heart failure hospitalization alone, did not differ significantly. After adjusting for comorbidities, females demonstrated lower primary composite endpoint (HR: 0.77; P = 0.009), lower all-cause mortality (HR: 0.62; P < 0.001), and lower cardiovascular mortality (subdistribution HR: 0.53; P = 0.011). CONCLUSIONS: Among patients with primary MR, females were older and presented with a different clinical and anatomical profile compared with males. Although optimal procedural results were lower in females, higher survival rates in females vs males suggest that mitral transcatheter edge-to-edge repair can be a good option regardless of sex.
No takes yet. Share an insight, caveat, or question.
Pezzola et al. (2026) conducted an observational in Primary mitral regurgitation (n=2,078). Female sex vs. Male sex was evaluated on Composite of 2-year all-cause mortality or heart failure hospitalization (HR 0.77, p=0.009). Female patients undergoing TEER for primary mitral regurgitation had a lower adjusted risk of 2-year all-cause mortality or heart failure hospitalization than males.
Synapse has enriched 10 related papers. Consider them for comparative context: